The cell proliferation antigen Ki-67 organises heterochromatin

  1. Michal Sobecki
  2. Karim Mrouj
  3. Alain Camasses
  4. Nikolaos Parisis
  5. Emilien Nicolas
  6. David Llères
  7. François Gerbe
  8. Susana Prieto
  9. Liliana Krasinska
  10. Alexandre David
  11. Manuel Eguren
  12. Marie-Christine Birling
  13. Serge Urbach
  14. Sonia Hem
  15. Jérôme Déjardin
  16. Marcos Malumbres
  17. Philippe Jay
  18. Vjekoslav Dulic
  19. Denis LJ Lafontaine
  20. Robert P Feil
  21. Daniel Fisher  Is a corresponding author
  1. Institute for Integrative Biology of the Cell, Université Paris Sud, France
  2. Montpellier Institute of Molecular Genetics, France
  3. Université Libre de Bruxelles, Belgium
  4. University of Montpellier, France
  5. Spanish National Cancer Research Centre, Spain
  6. Mouse Clinical Institute, France
  7. SupAgro, France

Abstract

Antigen Ki-67 is a nuclear protein expressed in proliferating mammalian cells. It is widely used in cancer histopathology but its functions remain unclear. Here, we show that Ki-67 controls heterochromatin organisation. Altering Ki-67 expression levels did not significantly affect cell proliferation in vivo. Ki-67 mutant mice developed normally and cells lacking Ki-67 proliferated efficiently. Conversely, upregulation of Ki-67 expression in differentiated tissues did not prevent cell cycle arrest. Ki-67 interactors included proteins involved in nucleolar processes and chromatin regulators. Ki-67 depletion disrupted nucleologenesis but did not inhibit pre-rRNA processing. In contrast, it altered gene expression. Ki-67 silencing also had wide-ranging effects on chromatin organisation, disrupting heterochromatin compaction and long-range genomic interactions. Trimethylation of histone H3K9 and H4K20 was relocalised within the nucleus. Finally, overexpression of human or Xenopus Ki-67 induced ectopic heterochromatin formation. Altogether, our results suggest that Ki-67 expression in proliferating cells spatially organises heterochromatin, thereby controlling gene expression.

Article and author information

Author details

  1. Michal Sobecki

    Department of Genome Biology, Institute for Integrative Biology of the Cell, Université Paris Sud, Gif-sur-Yvette, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Karim Mrouj

    Montpellier Institute of Molecular Genetics, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Alain Camasses

    Montpellier Institute of Molecular Genetics, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Nikolaos Parisis

    Montpellier Institute of Molecular Genetics, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Emilien Nicolas

    RNA Molecular Biology, Fonds de la Recherche Nationale, Université Libre de Bruxelles, Charleroi-Gosselies, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  6. David Llères

    Montpellier Institute of Molecular Genetics, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  7. François Gerbe

    Faculty of Sciences, University of Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Susana Prieto

    Montpellier Institute of Molecular Genetics, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Liliana Krasinska

    Montpellier Institute of Molecular Genetics, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Alexandre David

    Faculty of Sciences, University of Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Manuel Eguren

    Spanish National Cancer Research Centre, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  12. Marie-Christine Birling

    Mouse Clinical Institute, Illkirch-Graffenstaden, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Serge Urbach

    Faculty of Sciences, University of Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Sonia Hem

    Mass Spectrometry Platform MSPP, SupAgro, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  15. Jérôme Déjardin

    Faculty of Sciences, University of Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  16. Marcos Malumbres

    Spanish National Cancer Research Centre, Madrid, Spain
    Competing interests
    The authors declare that no competing interests exist.
  17. Philippe Jay

    Faculty of Sciences, University of Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  18. Vjekoslav Dulic

    Montpellier Institute of Molecular Genetics, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  19. Denis LJ Lafontaine

    RNA Molecular Biology, Fonds de la Recherche Nationale, Université Libre de Bruxelles, Charleroi-Gosselies, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  20. Robert P Feil

    Montpellier Institute of Molecular Genetics, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  21. Daniel Fisher

    Montpellier Institute of Molecular Genetics, Montpellier, France
    For correspondence
    daniel.fisher@igmm.cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: All animal experiments were performed in accordance with international ethics standards and were subjected to approval by the Animal Experimentation Ethics Committee of Languedoc Roussillon and the Ministry for Higher Education and Research

Copyright

© 2016, Sobecki et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 16,392
    views
  • 2,147
    downloads
  • 268
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michal Sobecki
  2. Karim Mrouj
  3. Alain Camasses
  4. Nikolaos Parisis
  5. Emilien Nicolas
  6. David Llères
  7. François Gerbe
  8. Susana Prieto
  9. Liliana Krasinska
  10. Alexandre David
  11. Manuel Eguren
  12. Marie-Christine Birling
  13. Serge Urbach
  14. Sonia Hem
  15. Jérôme Déjardin
  16. Marcos Malumbres
  17. Philippe Jay
  18. Vjekoslav Dulic
  19. Denis LJ Lafontaine
  20. Robert P Feil
  21. Daniel Fisher
(2016)
The cell proliferation antigen Ki-67 organises heterochromatin
eLife 5:e13722.
https://doi.org/10.7554/eLife.13722

Share this article

https://doi.org/10.7554/eLife.13722

Further reading

    1. Cancer Biology
    2. Cell Biology
    Xiangning Bu, Nathanael Ashby ... Inhee Chung
    Research Article

    Cell crowding is a common microenvironmental factor influencing various disease processes, but its role in promoting cell invasiveness remains unclear. This study investigates the biomechanical changes induced by cell crowding, focusing on pro-invasive cell volume reduction in ductal carcinoma in situ (DCIS). Crowding specifically enhanced invasiveness in high-grade DCIS cells through significant volume reduction compared to hyperplasia-mimicking or normal cells. Mass spectrometry revealed that crowding selectively relocated ion channels, including TRPV4, to the plasma membrane in high-grade DCIS cells. TRPV4 inhibition triggered by crowding decreased intracellular calcium levels, reduced cell volume, and increased invasion and motility. During this process, TRPV4 membrane relocation primed the channel for later activation, compensating for calcium loss. Analyses of patient-derived breast cancer tissues confirmed that plasma membrane-associated TRPV4 is specific to high-grade DCIS and indicates the presence of a pro-invasive cell volume reduction mechanotransduction pathway. Hyperosmotic conditions and pharmacologic TRPV4 inhibition mimicked crowding-induced effects, while TRPV4 activation reversed them. Silencing TRPV4 diminished mechanotransduction in high-grade DCIS cells, reducing calcium depletion, volume reduction, and motility. This study uncovers a novel pro-invasive mechanotransduction pathway driven by cell crowding and identifies TRPV4 as a potential biomarker for predicting invasion risk in DCIS patients.

    1. Cancer Biology
    2. Cell Biology
    Rui Hua, Jean X Jiang
    Insight

    Cell crowding causes high-grade breast cancer cells to become more invasive by activating a molecular switch that causes the cells to shrink and spread.